With 80 years of experience, UQUIFA’S business model is based on a combination of a quality manufacturing platform and track record of service and reliability. UQUIFA is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical and animal health industries globally. The Company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA.
Bidar in India manufactures KSM's.
Uquifa in 10 seconds
More about Uquifa
UQUIFA has a global customer base with clients in over 70 countries worldwide. In terms of IP, the Company has more than 150 active DMF´s filed and 20 CEP's approved. UQUIFA counts the major global generic and ethical companies amongst its customers. R&D and innovation remains at the core of the Company’s strategy. It continues to make balanced investment in personnel and facilities plants, people and processes to stay ahead of the technological curve.
To expand its manufacturing capabilities, UQUIFA aquired Barisintex with its headquarters and facilities in Sant Celoni, near Barcelona. This acquisition further consolidated UQUIFA´’s position as a leading supplier of Ranitidine and Cimetidine to the generics industry. During the mid- 1990s, UQUIFA expanded its business base by providing contract manufacturing services to the pharmaceutical and animal health industries. Gradually UQUIFA's customer list grew to include many of the leading pharmaceutical companies in the world